Gonadotropin Releasing Hormone Receptor (GNRHR) Antibody

Este producto es parte de GNRHR - Gonadotropin Releasing Hormone Receptor
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Gonadotropin Releasing Hormone Receptor (GNRHR) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx325723
tested applications
ELISA, WB, IF/ICC

Description

GNRHR Antibody is a Rabbit Polyclonal against GNRHR.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetGonadotropin Releasing Hormone Receptor (GNRHR)
HostRabbit
ReactivityHuman, Mouse
Recommended DilutionELISA: 1/5000, WB: 1/500 - 1/2000, IF/ICC: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationPurified by affinity chromatography.
Size 150 µg
Size 2100 µg
FormLiquid
Tested ApplicationsELISA, WB, IF/ICC
BufferPBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP30968
Gene ID2798
AliasGNRHR,luteinizing hormone-releasing hormone (LHRH) receptor,GNRHR1,LHRH receptor,Type I GnRHR,gnRH receptor,GnRH-R,GnRH I receptor,GnRHR,luliberin receptor ,LHRHR, GRHR, HH7, LHRHR,GnRH1 receptor
BackgroundAntibody anti-GNRHR
StatusRUO

Descripción

GNRHR is a G protein-coupled receptor (GPCR) expressed primarily in the anterior pituitary gland, where it binds gonadotropin-releasing hormone (GnRH). Upon activation, GNRHR stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which regulate gonadal function, steroidogenesis, and gametogenesis. GNRHR signaling occurs through Gq/11 proteins, activating phospholipase C (PLC), increasing intracellular calcium, and stimulating protein kinase C (PKC). It plays a central role in reproductive physiology, controlling the menstrual cycle in females and testosterone production in males. Mutations in GNRHR are linked to disorders such as hypogonadotropic hypogonadism, characterized by delayed puberty and infertility. GNRHR is also expressed in extra-pituitary tissues and certain cancers, such as breast, prostate, and ovarian cancers, where it regulates cell proliferation and survival. Therapeutically, GnRH agonists and antagonists are used to treat hormone-dependent conditions, including infertility, endometriosis, and cancers. GNRHR remains a critical target in reproductive medicine and oncology.

Related Products

EH1882

Human GNRHR(Gonadotropin-releasing hormone receptor) ELISA Kit

Ver Producto
EM0666

Mouse Gnrhr(Gonadotropin-releasing hormone receptor) ELISA Kit

Ver Producto
ER0581

Rat Gnrhr(Gonadotropin-releasing hormone receptor) ELISA Kit

Ver Producto